GINKGO BIOWORKS HOLDINGS INC (DNA) Stock Income Statement
NYSE:DNA - New York Stock Exchange, Inc. - US37611X2099 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 227.04M | 251.46M | 477.70M | 313.80M | 76.70M | |||
| Minority Interest Expense | 0.00 | 0.00 | 1.40M | 6.60M | 100.00K | |||
| Cost Of Goods | 44.55M | 54.01M | 204.20M | 129.70M | 15.60M | |||
| Gross Profit | 182.50M | 197.45M | 273.50M | 184.10M | 61.00M | |||
| Operating Expenses | 665.80M | 773.47M | 2.44B | 2.01B | 198.10M | |||
| Research and Development | 424.06M | 580.62M | 1.05B | 1.15B | 159.80M | |||
| Selling, General, and Administrative Expenses | 241.74M | 192.85M | 1.38B | 863.00M | 38.30M | |||
| Operating Income | -483.31M | -576.02M | -2.16B | -1.83B | -137.00M | |||
| Interest Income/Expense | 11.71M | -338.00K | -76.90M | -90.40M | -3.90M | |||
| Other Income/Expense | 28.39M | 14.31M | 132.60M | 80.70M | 16.10M | |||
| Non Recurring Items | -104.29M | -330.89M | -14.30M | N/A | N/A | |||
| Income Before Taxes | -547.51M | -892.94M | -2.12B | -1.84B | -124.80M | |||
| Income Tax | -479.00K | -71.00K | -15.00M | -1.50M | 1.90M | |||
| Net Income | -547.03M | -892.87M | -2.10B | -1.83B | -126.60M | |||
| EBITDA | -420.29M | -505.51M | -2.12B | -1.80B | -123.14M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -10.54 | -18.37 | -1.25 | -1.35 | -0.07 | |||
| Non GAAP EPS | -8.94 | -18.80 | -49.20 | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 80.38% | 78.52% | 57.25% | 58.67% | 79.53% | |||
| Profit Margin | -240.94% | -355.08% | -440.63% | -583.17% | -165.06% | |||
| Operating Profit Margin | -212.87% | -229.08% | -452.75% | -582.70% | -178.62% | |||
All data in USD